MOVAPO
PALADIN LABS INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MOVAPO in Canada?
Yes. MOVAPO 10MG has an active shortage reported to Health Canada (last updated October 16, 2023).
Why is MOVAPO not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MOVAPO be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MOVAPO
PALADIN PHARMA INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02459132
Strength
10MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
APOMORPHINE HYDROCHLORIDE
Tier
Unrated
Last Updated
2023-10-16
Reason for Shortage
Disruption of the manufacture of the drug.